Oral exposure to inorganic arsenic: Evaluation of its carcinogenic and non-carcinogenic effects

Critical Reviews in Toxicology

Volumn 39, Issue 4, 2009, Pages 271-298

  Schuhmacherwolz, Ulrike ^a   Dieter, Hermann H ^b   Klein, Dominik ^c   Schneider, Klaus ^a  

^a Forschungs und Beratungsinstitut Gefahrstoffe GmbH FoBiG   (Germany)

^b UMWELTBUNDESAMT   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Cancer; Drinking water; Inorganic arsenic; Risk assessment; Skin lesions

Indexed keywords

ARSENIC; CACODYLIC ACID; DNA METHYLTRANSFERASE; DRINKING WATER; GLUTATHIONE TRANSFERASE; METHANEARSONIC ACID; WELL WATER; CARCINOGEN;

AGE DISTRIBUTION; ARSENIC POISONING; BLADDER CANCER; CANCER RISK; CARCINOGENICITY; CELL PROLIFERATION; CEREBROVASCULAR DISEASE; CHROMOSOME ABERRATION; COGNITIVE DEFECT; CYTOTOXICITY; DEMETHYLATION; DISORDERS OF DNA SYNTHESIS AND REPAIR; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; FLUID INTAKE; GASTROINTESTINAL SYMPTOM; GENETIC POLYMORPHISM; GENOTOXICITY; HUMAN; HYPERKERATOSIS; HYPERPIGMENTATION; INTELLECTUAL IMPAIRMENT; ISCHEMIC HEART DISEASE; LUNG CANCER; METHYLATION; NERVE CONDUCTION DISORDER; NEWBORN DEATH; NONHUMAN; NUTRITIONAL STATUS; OXIDATIVE STRESS; PREMATURITY; PREVALENCE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN DEFECT; SPONTANEOUS ABORTION; STILLBIRTH; TOXICOKINETICS; URINARY EXCRETION; CHEMICALLY INDUCED DISORDER; METABOLISM; NEOPLASM; SKIN DISEASE; WATER POLLUTANT; WATER SUPPLY;

ARSENIC; ARSENIC POISONING; CARCINOGENS; NEOPLASMS; RISK ASSESSMENT; SKIN DISEASES; WATER POLLUTANTS; WATER SUPPLY;

EID: 68849124789     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.1080/10408440802291505     Document Type: Review

References (231)

1. Abdullah, M., and Wheeler, E. F. (1985). Seasonal variations, and the intra-household distribution of food in a Bangladeshi village. Am. J. Clin. Nutr. 41:1305-1313.
2. Ahmad, S. A., Sayed, M. H. S. U., Barua, S., Khan, M. H., Faruquee, M. H., Jalil, A., Hadi, S. A., and Talukder, H. K. (2001). Arsenic in drinking water and pregnancy outcomes. Environ. Health Perspect. 109(6):629-631.
3. Ahsan, H., Chen, Y., Wang, Q., Slavkovich, V., Graziano, J. H., and Santella, R. M. (2003). DNA repair gene XPD and susceptibility to arsenic-induced hyperkeratosis. Toxicol. Lett. 143:123-131.
4. Ahsan, H., Chen, Y., Parvez, F., Zablotska, L., Argos, M., Hussain, I., Momotaj, H., Levy, D., Chen, Z., Slavkovich, V., van Geen, A., Howe, G. R., and Graziano, J. H. (2006a). Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the Health Efects of Arsenic Longitudinal Study. Am. J. Epidemiol. 163(12):1138-1148.
5. Ahsan, H., Chen, Y., Parvez, F., Argos, M., Hussain, A., Momotaj, H., Levy, D., van Geen, A., Howe, G., and Graziano, J. H. (2006b). Health Efects of Arsenic Longitudinal Study (HEALS): Description of a multidisciplinary epidemiologic investigation. J. Expo. Sci. Envion. Epidemiol. 16:191-205.
6. Ahsan, H., Chen, Y., Kibriya, M. G., Slavkovich, V., Parvez, F., Jasmine, F., Gamble, M. V., and Graziano, J. H. (2007). Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol. Biomarkers Prev. 16(6):1270-1278.
7. Alain, G., Tousignant, J., and Rozenfarb, E. (1993). Chronic arsenic toxicity. Int. J. Dermatol. 32:899-901.
8. An, Y., Gao, Z., Wang, Z., Yang, S., Liang, J., Feng, Y., Kato, K., Nakano, M., Okada, S., and Yamanaka, K. (2004). Immunohistochemical analysis of oxidative DNA damage in arsenic-related human skin samples from arsenic-contaminated area of China. Cancer Lett. 214(1):11-18.
9. Andrew, A. S., Karagas, M. R., and Hamilton, J. W. (2003). Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. Int. J. Cancer 104:263-268.
10. Andrew, A. S., Burgess, J. L., Meza, M. M., Demidenko, E., Waugh, M. G., Hamilton, J. W., and Karagas, M. R. (2006). Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Environ. Health Perspect. 114(8):1193-1198.
11. Arnold, L. L., Eldan, M., van Gemert, M., Capen, C. C., and Cohen, S. M. (2003). Chronic studies evaluating the carcinogenicity of monomethylarsonic acid in rats and mice. Toxicology 190:197-219.
12. Arnold, L. L., Eldan, M., Nyska, A., van Gemert, M., and Cohen, S. M. (2006). Dimethylarsinic acid: Results of chronic toxicity/oncogenicity studies in F344 rats and in B6C3F1 mice. Toxicology 223:82-100.
13. ATSDR (Agency for Toxic Substances and Disease Registry). (2005). Toxicological profle for arsenic. Draft for public comment. Update. US Department of Health and Human Services, Public Health Service.
14. Ayotte, J. D., Baris, D., Cantor, K. P., Colt, J., Robinson Jr., G. R., Lubin, J. H., Karagas, M., Hoover, R. N., Fraumeni Jr., J. F., and Silverman, D. T. (2006). Bladder cancer mortality and private well use in New England: An ecological study. J. Epidemiol. Community Health 60:168-172.
15. Banerjee, M., Sarkar, J., Das, J. K., Mukherjee, A., Sarkar, A. K., Mondal, L., and Giri, A. K. (2007). Polymorphism in the ERCC2 codon 751 is associated with arsenic-induced premalignant hyperkeratosis and signifcant chromosome aberrations. Carcinogenesis 28(3):672-676.
16. Basu, A., Mahata, J., Roy, A. K., Sarkar, J. N., Poddar, G., Nandy, A. K., Sarkar, P. K., Dutta, P. K., Banerjee, A., Das, M., Ray, K., RoyChoudhury, S., Natarajan, A. T., Nilsson, R., and Giri, A. K. (2002). Enhanced frequency of micronuclei in individuals exposed to arsenic through drinking water in West Bengal, India. Mut. Res. 516(1-2):29-40.
17. Bates, M. N., Smith, A. H., and Cantor, K. P. (1995). Case-control study of bladder cancer and arsenic in drinking water. Am. J. Epidemiol. 141:523-530.
18. Bates, M. N., Rey, O. A., Biggs, M. L., Hopenhayn, C., Moore, L. E., Kalman, D., Steinmaus, C., and Smith, A. H. (2004). Case-control study of bladder cancer and exposure to arsenic in Argentinia. Am. J. Epidemiol. 159:381-389.
19. Beane Freeman, L. E., Dennis, L. K., Lynch, C. F., Torne, P. S., and Just, C. L. (2004). Toenail arsenic content and cutaneous melanoma in Iowa. Am. J. Epidemiol. 160:679-687.
20. Benbrahim-Tallaa, L., and Waalkes, M. P. (2008). Inorganic arsenic and human prostate cancer. Environ. Health Perspect. 116(2):158-164
21. Biswas, S., Talukder, G., and Sharma, A. (1999). Prevention of cytotoxic efects of arsenic by short-term dietary supplementation with selenium in mice in vivo. Mut. Res. 441:155-160.
22. Borak, J., and Hosgood, H.D. (2007). Seafood arsenic: Implications for human risk assessment. Regul. Toxicol. Pharmacol. 47:204-212.
23. Bredfeldt, T. G., Jagadish, B., Eblin, K. E., Mash, E. A., and Gandolf, A. J. (2006). Monomethylarsonous acid induces transformation of human bladder cells. Toxicol. Appl. Pharmacol. 216(1):69-79.
24. Brima, E. I., Jenkins, R. O., Lythgoe, P. R., Gault, A. G., Polya, D. A., and Haris, P. I. (2007). Efect of fasting on the pattern of urinary arsenic excretion. J Environ Monit 9(1):98-103.
25. Brown, K. G. (2007). How creditable are cancer risk estimates from the S.W. Taiwan database for arsenic in drinking water? HERA 13:180-190.
26. Brown, K. G., and Ross, G. L. (2002). Arsenic, drinking water, and health: A position paper of the American Council on Science and Health. Regul. Toxicol. Pharmacol. 36:162-174.
27. Buchet, J. P., Lauwerys, R., and Roels, H. (1981a). Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int Arch Occup Environ Health 48(1):71-80.
28. Buchet, J. P., Lauwerys, R., and Roels, H. (1981b). Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers. Int Arch Occup Environ Health 48(2):111-118.
29. Cantor, K. P., and Lubin, J. H. (2007). Arsenic, internal cancers, and issues in inference from studies of low-level exposures in human populations. Toxicol. Appl. Pharmacol. 222:252-257.
30. Chanda, S., Dasgupta, U. B., Guha Mazumder, D., Gupta, M., Chaudhuri, U., Lahiri, S., Das, S., Ghosh, N., and Chatterjee, D. (2006). DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci 89(2):431-437.
31. Chen, C.-J., Chuang, Y.-C., Lin, T.-M., and Wu, H.-Y. (1985). Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high arsenic artesian well water and cancers. Cancer Res 45:5895-5899.
32. Chen, C.-J., Chiou, H.-Y., Chiang, M.-H., Lin, L.-J., and Tai, T.-Y. (1996). Dose- response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Tromb Vasc Biol 16:504-510.
33. Chen, C. L., Hsu, L. I., Chiou, H. Y., Hsueh, Y. M., Chen, S. Y., Wu, M. M., and Chen, C. J. (2004). Ingested arsenic, cigarette smoking, and lung cancer risk: A follow-up study in arseniasis-endemic areas in Taiwan. JAMA 292:2984-2990.
34. Chen, Y., Graziano, J. H., Parvez, F., Hussain, I., Momotaj, H., van Geen, A., Howe, G. R., and Ahsan, H. (2006). Modifcation of risk of arsenic-induced skin lesions by sunlight exposure, smoking, and occupational exposures in Bangladesh. Epidemiology 17:459-467.
35. Chen, Y., Factor-Litvak, P., Howe, G. R., Graziano, J. H., Brandt-Rauf, P., Parvez, F., van Geen, A., and Ahsan, H. (2007a). Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: A population-based, cross-sectional study. Am. J. Epidemiol. 165(5):541-552.
36. Chen, Y., Hall, M., Graziano, J. H., Slavkovich, V., van Geen, A., Parvez, F., and Ahsan, H. (2007b). A prospective study of blood selenium levels and the risk of arsenic-related premalignant skin lesions. Cancer Epidemiol. Biomarkers Prev. 16:207-213.
37. Chen, Y. C., Guo, Y. L., Su, H. J., Hsueh, Y. M., Smith, T. J., Ryan, L. M., Lee, M. S., Chao, S. C., Lee, J. Y., and Christiani, D. C. (2003a). Arsenic methylation and skin cancer risk in southwestern Taiwan. J. Occup. Environ. Med. 45(3):241-248.
38. Chen, Y. C., Su, H. J., Guo, Y. L., Hsueh, Y. M., Smith, T. J., Ryan, L. M., Lee, M. S., and Christiani, D. C. (2003b). Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14(4):303-310.
39. Chiou, H.-Y., Hsueh, Y.-M., Hsieh, L.-L., Hsu, L.-I., Hsu, Y.-H., Hsieh, F.-I., Wei, M.-L., Chen, H.-C., Yang, H.-T., Leu, L.-C., Chu, T.-H., Chen-Wu, C., Yang, M.-H., and Chen, C.-J. (1997a). Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mut. Res. 386(3):197-207.
40. Chiou, H.-Y., Huang, W.-I., Su, C.-L., Chang, S.-F., Hsu, Y.-H., and Chen, C. J. (1997b). Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 28:1717-1723.
41. Chiou, H. Y., Chiou, S. T., Hsu, Y. H., Chou, Y. L., Tseng, C. H., Wie, M. L., and Chen, C. J. (2001). Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am. J. Epidemiol. 153:411-418.
42. Chiu, H. F., Ho, S. C., Wang, L. Y., Wu, T. N., and Yang, C. Y. (2004). Does arsenic exposure increase the risk for liver cancer? J. Toxicol. Environ. Health A 67(19):1491-1500.
43. Cohen, S. M., Arnold, L. L., Eldan, M., Lewis, A. S., and Beck, B. D. (2006). Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit. Rev. Toxicol. 36(2):99-133.
44. Council of the European Union (1998). Council Directive 98/83/EC of November 1998 on the quality of water intended for human consumption.
45. Danaee, H., Nelson, H. H., Liber, H., Little, J. B., and Kelsey, K. T. (2004). Low dose exposure to sodium arsenite synergistically interacts with UV radiation to induce mutations and alter DNA repair in human cells. Mutagenesis 19(2):143-148.
46. Deknudt, G., Léonard, A., Arany, J., Jenar-Du Buisson, G., and Delavignette, E. (1986). In vivo studies in male mice on the mutagenic efects of inorganic arsenic. Mutagenesis 1:33-34.
47. Dieter, H. H. (1991). Occurrence and toxicology of arsenic and its signifcance for human health in drinking water [in German]. In: Die Trinkwasserverordnung. Einführung und Erläuterungen für Wasserversorgungsunternehmen und Überwachungsbehörden, Aurand, K. et al., eds, pp. 154-171.
48. Erich Schmidt Verlag, Berlin. Dopp, E., Hartmann, L. M., Florea, A.-M., von Recklinghausen, U., Pieper, R., Shokouhi, B., Rettenmeier, A. W., Hirner, A. V., and Obe, G. (2004). Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic efects in Chinese hamster ovary (CHO) cells. Toxicol. Appl. Pharmacol. 201:156-165.
49. Dopp, E., Hartmann, L. M., von Recklinghausen, U., Florea, A. M., Rabieh, S., Zimmermann, U., Shokouhi, B., Yadav, S., Hirner, A. V., and Rettenmeier, A. W. (2005). Forced uptake of trivalent and pentavalent methylated and inorganic arsenic and its cyto-/genotoxicity in fbroblasts and hepatoma cells. Toxicol. Sci. 87(1):46-56.
50. Dulout, F. N., Grillo, C. A., Seoane, A. I., Maderna, C. R., Nilsson, R., Vahter, M., Darroudi, F., and Natarajan, A. T. (1996). Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from Northwestern Argentina exposed to arsenic in drinking water. Mut. Res. 370(3,4):151-158.
51. Eastmond, D. A., and Tucker, J. D. (1989). Identifcation of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody. Environ. Mol. Mutagen. 13:34-43.
52. Eblin, K. E., Bowen, M. E., Cromey, D. W., Bredfeldt, T. G., Mash, E. A., Lau, S. S., and Gandolf, A. J. (2006). Arsenite and monomethylarsonous acid generate oxidative stress response in human bladder cell culture. Toxicol. Appl. Pharmacol. 217(1):7-14.
53. Environmental Protection Agency. (1981). Community health associated with arsenic in drinking water in Millard County, Utah. Environmental Protection Agency, Cincinnati, OH.
54. Environmental Protection Agency. (2001). National primary drinking water regulations, arsenic and clarifcations to compliance and new source contaminants monitoring, fnal rule. Federal Register 66:6976-7066.
55. Environmental Protection Agency. (2005). Toxicological review of ingested inorganic arsenic. Draft. US Environmental Protection Agency, Washington, DC.
56. Environmental Protection Agency. (2007). Integrated Risk Information system (IRIS). Available at: http:/www.epa.gov./iris [Accessed: January 2007.]
57. European Chemicals Bureau (2007). European chemical substances information system (ESIS). Available at: http://ecb.jrc.it/esis [Accessed August 2007.]
58. Exponent. (2005). Epidemiologic studies of low-level arsenic exposure in drinking water and bladder cancer: A review and meta-analysis. Doc. no. BE02909.001 0201 0805 PM25.
59. Exponent, Washington, DC. Ferreccio, C., Gonzalez, C., Milosavljevic, V., Marshall, G., Sancha, A. M., and Smith, A. H. (2000). Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 11:673-679.
60. Federal Republic of Germany. (1991). Ordinance from December 12 1990 on drinking water and water for food production enterprises [in German]. BGBl. I 2613.
61. Florea, A.-M., Yamoah, E.N., and Dopp, E. (2005). Intracellular calcium disturbances induced by arsenic and its methylated derivatives in relation to genomic damage and apoptosis induction. Environ. Health Perspect. 113(6):659-664.
62. Frost, F. , Craun, C., and Brown, K. G. (2002). Detection of excess arsenic-related cancer risk. Environ. Health Perspect. 110:A12-A13.
63. Gamble, M. V., Liu, X., Ahsan, H., Pilsner, J. R., Ilievski, V., Slavkovich, V., Parvez, F., Levy, D., Factor-Litvak, P., and Graziano, J. H. (2005). Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ. Health Perspect. 113:1683-1688.
64. Gamble, M. V., Liu, X., Ahsan, H., Pilsner, J. R., Ilievski, V., Slavkovich, V., Parvez, F., Chen, Y., Levy, D., Factor-Litvak, P., and Graziano, J. H. (2006). Folate and arsenic metabolism: A double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am. J. Clin. Nutr. 84:1093-1101.
65. Gebel, T. (1998). Suppression of arsenic-induced chromosome mutagenicity by antimony. Mut. Res. 412:213-218.
66. Gebel, T. W. (2001). Genotoxicity of arsenical compounds. Int. J. Hyg. Environ. Health 203:249-262.
67. Gebel, T., Christensen, S., and Dunkelberg, H. (1997). Comparative and environmental genotoxicity of antimony and arsenic. Anticancer Res. 17:2603-2607.
68. Gentry, P. R., Covington, T. R., Mann, S., Shipp, A. M., Yager, J. W., and Clewell, H. J. (2004). Physiologically based pharmacokinetic modeling of arsenic in the mouse. J. Toxicol. Environ. Health A 67(1):43-71.
69. Ghosh, P., Basu, A., Mahata, J., Basu, S., Sengupta, M., Das, J. K., Mukherjee, A., Sarkar, A. K., Mondal, L., Ray, K., and Giri, A. K. (2006). Cytogenetic damage and genetic variants in the individuals susceptible to arsenic-induced cancer through drinking water. Int. J. Cancer 118(10):2470-2478.
70. Gómez, S. E., del Razo, L. M., and Munoz Sanchez, J. L. (2005). Induction of DNA damage by free radicals generated either by organic or inorganic arsenic (AsIII, MMAIII, and DMAIII) in cultures of B and T lymphocytes. Biol. Trace Elem. Res. 108(1-3):115-126.
71. Gonsebatt, M. E., Vega, L., Salazar, A. M., Montero, R., Guzman, P., Blas, J., Del Razo, L. M., Garcia-Vargas, G., Albores, A., Cebrian, M. E., Kelsh, M., and Ostrosky-Wegman, P. (1997). Cytogenetic efects in human exposure to arsenic. Mut. Res. 386(3):219-228.
72. Grobe, J. W. (1977). Gutachterliche und therapeutische Befunde und Beobachtungen bei Moselwinzern mit Arsenintoxikationsspätfolgeschä digung. Berufsdermatosen 25(3):124-130.
73. Grobe, J. W. (1982). Dupuytren'sche Kontrakturen bei Moselwinzern mit Arsenspätfolgeschädigung. Derm Beruf Umwelt 30(6):196-198.
74. Guha Mazumder, D. N., Haque, R., Ghosh, N., De, B. K., Santra, A., Chakraborty, D., and Smith, A. H. (1998). Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int. J. Epidemiol. 27:871-877.
75. Guo, H. R. (2004). Arsenic level in drinking water and mortality of lung cancer (Taiwan). Cancer Causes Control 15:171-177.
76. Guo, X., Liu, Z., Huang, C., and You, L. (2006). Levels of arsenic in drinking-water and cutaneous lesions in Inner Mongolia. J. Health Popul. Nutr. 24:214-220.
77. Hall, M., Chen, Y., Ahsan, H., Slavkovich, V., van Geen, A., Parvez, F., and Graziano, J. (2006). Blood arsenic as a biomarker of arsenic exposure: results from a prospective study. Toxicology 225(2-3):225-233.
78. Haque, R., Mazumder, D. N., Samanta, S., Ghosh, N., Kalman, D., Smith, M. M., Mitra, S., Santra, A., Lahiri, S., Das, S., De, B. K., and Smith, A. H. (2003). Arsenic in drinking water and skin lesions: Dose-response data from West Bengal, India. Epidemiology 14(2):174-182.
79. Harrington-Brock, K., Cabrera, M., Collard, D. D., Doerr, C. L., McConnell, R., Moore, M. M., Sandoval, H., and Fuscoe, J. C. (1999). Efects of arsenic exposure on the frequency of HPRT-mutant lymphocytes in a population of copper roasters in Antofagasta, Chile: A pilot study. Mut. Res. 431:247-257.
80. Hartwig, A., Groblinghof, U. D., Beyersmann, D., Natarajan, A. T., Filon, R., and Mullenders, L. H. (1997). Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fbroblasts. Carcinogenesis 18:399-405. (Pubitemid 28132435)
81. Hartwig, A., Pelzer, A., Asmuss, M., and Bürkle, A. (2003). Very low concentrations of arsenite suppress poly(ADP-ribosyl)ation in mammalian cells. Int. J. Cancer 104:1-6.
82. Hassauer, M., and Kalberlah, F. (1999). Arsen und Verbindungen. In: Gefährdungsabschätzung von Umweltschadstofen. Ergänzbares Handbuch toxikologischer Basisdaten und ihre Bewertung, Kennzifer D 095.
83. Eikmann, T., Heinrich, U., Heinzow, B., Konietzka, R.eds. Erich Schmidt Verlag, Berlin.
84. Hayakawa, T., Kobayashi, Y., Cui, X., and Hirano, S. (2005). A new metabolic pathway of arsenite: Arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch. Toxicol. 79(4):183-191.
85. He, X.-Q., Chen, R., Yang, P., Li, A.-P., Zhou, J.-W., and Liu, Q.-Z. (2007). Biphasic efect of arsenite on cell proliferation and apoptosis is associated with the activation of JNK and ERK1/2 in human embryo lung fbroblast cells. Toxicol. Appl. Pharmacol. 220(1):18-24.
86. Hopenhayn, C., Ferreccio, C., Browning, S. R., Huang, B., Peralta, C., Gibb, H., and Hertz-Picciotto, I. (2003). Arsenic exposure from drinking water and birth weight. Epidemiology 14(5):593-602.
87. Hopenhayn-Rich, C., Biggs, M. L., Kalman, D. A., Moore, L. E., and Smith, A. H. (1996). Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ. Health Perspect. 104(11):1200-1207.
88. Hsueh, Y. M., Chiou, H. Y., Huang, Y. L., Wu, W. L., Huang, C. C., Yang, M. H., Lue, L. C., Chen, G. S., and Chen, C. J. (1997). Serum beta-carotene level, arsenic methylation capability and incidence of arsenic-induced skin cancer. Cancer Epidemiol. Biomarkers Prev. 6:589-596.
89. Huang, Y.-K., Tseng, C.-H., Huang, Y.-L., Yang, M.-H., Chen, C.-J., and Hsueh, Y.-M. (2007). Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. Toxicol. Appl. Pharmacol. 218(2):135-142.
90. Hughes, M. F. (2006). Biomarkers of exposure: A case study with inorganic arsenic. Environ. Health Perspect. 114: 1790-1796.
91. International Agency for Research on Cancer. (2004). IARC monographs on the evaluation of carcinogenic risks to humans. Vol.84. Some drinking-water disinfectants and contaminants, including arsenic. WHO, World Health Organization, Geneva.
92. Kapaj, S., Peterson, H., Liber, K., and Bhattacharya, P. (2006). Human health efects from chronic arsenic poisoning-A review. J. Environ. Sci. Health A 41(10):2399-2428.
93. Karagas, M. R., Tosteson, T. D., Blum, J., Klaue, B., Weiss, J. E., Stannard, V., Spate, V., and Morris, J. S. (2000). Measurement of low levels of arsenic exposure: A comparison of water and toenail concentrations. Am. J. Epidemiol. 152:84-90.
94. Karagas, M. R., Stukel, T. A., Morris, J. S., Tosteson, T. D., Weiss, J. E., Spencer, S. K., and Greenberg, E. R. (2001a). Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am. J. Epidemiol. 153:559-565.
95. Karagas, M. R., Le, C. X., Morris, S., Blum, J., Lu, X., Spate, V., Carey, M., Stannard, V., Klaue, B., and Tosteson, T. D. (2001b). Markers of low level arsenic exposure for evaluating human cancer risks in a US population. Int. J. Occup. Med. Environ. Health 14:171-175.
96. Karagas, M. R., Stukel, T. A., and Tosteson, T. D. (2002). Assessment of cancer risk and environmental levels of arsenic in New Hampshire. Int. J. Hyg. Environ. Health 205:85-94.
97. Karagas, M. R., Tosteson, T. D., Morris, J. S., Demidenko, E., Mott, L. A., Heaney, J., and Schned, A. (2004). Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 15:465-472.
98. Kashiwada, E., Kuroda, K., and Endo, G. (1998). Aneuploidy induced by dimethylarsinic acid in mouse bone marrow cells. Mut. Res. 413:33-38.
99. Kile, M. L., Houseman, E. A., Breton, C. V. , Smith, T., Quamruzzaman, Q., Rahman, M., Mahiuddin, G., and Christiani, D. C. (2007). Dietary arsenic exposure in Bangladesh. Environ. Health Perspect. 115(6):889-893.
100. Kitchin, K. T., and Wallace, K. (2008). Te role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity. J. Inorg. Bioch. 102(3):532-539.
101. Kligerman, A. D., Doerr, C. L., Tennant, A. H., Harrington-Brock, K., Allen, J. W., Winkfeld, E., Poorman-Allen, P., Kundu, B., Funasaka, K., Roop, B. C., Mass, M. J., and DeMarini, D. M. (2003). Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: Induction of chromosomal mutations but not gene mutations. Environ. Mol. Mutagen. 42:192-205.
102. Knobeloch, L. M., Zierold, K. M., and Anderson, H. A. (2006). Association of arsenic-contaminated drinking-water with prevalence of skin cancer in Wisconsin's Fox River Valley. J. Health Popul. Nutr. 24:206-213.
103. Krishnamohan, M., Seawright, A. A., and Ng, J. C. (2006). Monomethylarsonous acid (MMAIII) is carcinogenic in mice. Abstract number 2086. Toxicologist 90:427.
104. Kumagai, Y., and Sumi, D. (2007). Arsenic: Signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Annu. Rev. Pharmacol. Toxicol. 47:243-262.
105. Lai, M. S., Hsueh, Y. M., Chen, C. J., Shyu, M. P., Kuo, T. L., Wu, M. M., and Tai, T. Y. (1994). Ingested inorganic arsenic and prevalence of diabetes mellitus. Am. J. Epidemiol. 139:484-492.
106. Lamm, S. H., Byrd, D. M., Kruse, M. B., Feinleib, M., and Lai, S. H. (2003). Bladder cancer and arsenic exposure: Diferences in the two populations enrolled in a study in southwest Taiwan. Biomed. Environ. Sci. 16(4):355-368.
107. Lamm, S. H., Engel, A., Kruse, M. B., Feinleib, M., Byrd, D. M., Lai, S., and Wilson, R. (2004). Arsenic in drinking water and bladder cancer mortality in the United States: An analysis based on 133 US counties and 30 years of observation. J. Occup. Environ. Med. 46:298-306. (Pubitemid 38366634)
108. Lamm, S. H., Engel, A., Penn, C. A., Chen, R., and Feinleib, M. (2006). Arsenic cancer risk confounder in Southwest Taiwan data set. Environ. Health Perspect. 114(7):1077-1082.
109. Lamm, S. H., Luo, Z.-D., Bo, F.-B., Zhang, G.-Y., Zhang, Y.-M., Wilson, R., Byrd, D. M., Lai, S., Li, F.-X., Polkanov, M., Tong, Y., Loo, L., Tucker, S. B. and the Inner Mongolia Cooperative Arsenic Project (2007). An epidemiologic study of arsenic-related skin disorders and skin cancer and the consumption of arsenic-contaminated well waters in Huhhot, Inner Mongolia, China. HERA 13(4):713-746.
110. Le, X. C., Lu, X., Ma, M., Cullen, W. R., Aposhian, H. V., and Zheng, B. (2000). Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 72(21):5172-5177.
111. Lee, T.-C., Oshimura, M., and Barrett, J. C. (1985). Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic efects in Syrian hamster embryo cells in culture. Carcinogenesis 6:1421-1426.
112. Lerda, D. (1994). Sister-chromatid exchange (SCE) among individuals chronically exposed to arsenic in drinking water. Mut. Res. 312:111-120.
113. Lewinska, D., Palus, J., Stepnik, M., Dziubaltowska, E., Beck, J., Rydzynski, K., Natarajan, A. T., and Nilsson, R. (2007). Micronucleus frequency in peripheral blood lymphocytes and buccal mucosa cells of copper smelter workers, with special regard to arsenic exposure. Int Arch Occup Environ Health 80(5):371-380.
114. Lewis, D. R., Southwick, J. W., Ouellet-Hellstrom, R., Rench, J., and Calderon, R. L. (1999). Drinking water arsenic in Utah: A cohort mortality study. Environ. Health Perspect. 107:359-365.
115. Li, J. H., and Rossman, T. G. (1989). Mechanisms of comutagenesis of sodium arsenite with N-methyl-N-nitrosurea. Biol. Trace. Elem. Res. 21:373-381.
116. Li, X. S., Zhi, J. L., and Gao, R. O. (1995) Efect of fuoride exposure on intelligence in children. Fluoride 28(4):189-192.
117. Lindberg, A.-L., Kumar, R., Goessler, W., Tirumaran, R., Gurzau, E., Koppova, K., Rudnai, P., Leonardi, G., Fletcher, T., and Vahter, M. (2007). Metabolism of low dose inorganic arsenic in a Central European population-Infuence of gender and genetic polymorphisms. Environ. Health Perspect. 115(7):1081-1086.
118. Lofredo, C. A., Aposhian, H. V., Cebrian, M. E., Yamauchi, H., and Silbergeld, E. K. (2003). Variability in human metabolism of arsenic. Environ. Res. 92(2):85-91.
119. Lüchtrath, H. (1983). Te consequences of chronic arsenic poisoning among Moselle wine growers. Pathoanatomical investigations of post-mortem examinations performed between 1060 and 1977. J. Cancer Res. Clin. Oncol. 105(2):173-182.
120. Luster, M. I., and Simeonova, P. P. (2004). Arsenic and urinary bladder cell proliferation. Toxicol. Appl. Pharmacol. 198:419-423.
121. Mäki-Paakkanen, J., Kurttio, P., Paldy, A., and Pekkanen, J. (1998). Association between the clastogenic efect in peripheral lymphocytes and human exposure to arsenic through drinking water. Environ. Mol. Mutagen. 32(4):301-313.
122. Maharjan, M., Watanabe, C., Ahmad, S. A., Umezaki, M., and Ohtsuka, R. (2007). Mutual interaction between nutritional status and chronic arsenic toxicity due to groundwater contamination in an area of Terai, lowland Nepal. J. Epidemiol. Community Health 61(5):389-394.
123. Mahata, J., Basu, A., Ghoshal, S., Sarkar, J. N., Roy, A. K., Poddar, G., Nandy, A. K., Banerjee, A., Ray, K., Natarajan, A. T., Nilsson, R., and Giri, A. K. (2003). Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India. Mut. Res. 534(1-2):133-143.
124. Mahata, J., Ghosh, P., Sarkar, J. N., Ray, K., Natarajan, A. T., and Giri, A. K. (2004). Efect of sodium arsenite on peripheral lymphocytes in vitro: individual susceptibility among a population exposed to arsenic through the drinking water. Mutagenesis 19(3):223-229.
125. Mandal, B. K., Ogra, Y., Anzai, K., and Suzuki, K. T. (2004). Speciation of arsenic in biological samples. Toxicol. Appl. Pharmacol. 198(3):307-318.
126. Mann, S., Droz, P.-O., and Vahter, M. (1996a). A physiologically based pharmacokinetic model for arsenic exposure. I. Development in hamsters and rabbits. Toxicol. Appl. Pharmacol. 137(1):8-22. (Pubitemid 26095854)
127. Mann, S., Droz, P.-O., and Vahter, M. (1996b). A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans. Toxicol. Appl. Pharmacol. 140(2):471-486. (Pubitemid 26366872)
128. Marcos, R., Martínez, V., Hernandez, A., Creus, A., Sekaran, C., Tokunaga, H., and Quinteros, D. (2006). Metabolic profle in workers occupationally exposed to arsenic: Role of GST polymorphism. J. Occup. Environ. Med. 48(3):334-341.
129. Marshall, G., Ferreccio, C., Yuan, Y., Bates, M. N., Steinmaus, C., Selvin, S., Liaw, J., and Smith, A. H. (2007). Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J. Natl. Cancer. Inst. 99(12):920-928.
130. Marsit, C. J., Karagas, M. R., Danaee, H., Liu, M., Andrew, A., Schned, A., Nelson, H. H., and Kelsey, K. T. (2006a). Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis 27(1):112-116. (Pubitemid 43025250)
131. Marsit, C. J., Karagas, M. R., Schned, A., Kelsey, K. T. (2006b). Carcinogen exposure and epigenetic silencing in bladder cancer. Annals of the New York Academy of Sciences 1076:810-821. (Pubitemid 44955311)
132. Martínez, V. , Creus, A., Venegas, W., Arroyo, A., Beck, J. P. , Gebel, T. W., Surrallés, J., and Marcos, R. (2004). Evaluation of micronucleus induction in a Chilean population environmentally exposed to arsenic. Mut. Res. 564(1):65-74.
133. Mass, M. J., Tennant, A., Roop, B. C., Cullen, W. R., Styblo, M., Tomas, D. J., and Kligerman, A. D. (2001). Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 14:355-361.
134. McCarty, K. M., Chen, Y.-C., Quamruzzaman, Q., Rahman, M., Mahiuddin, G., Hsueh, Y.-M., Su, L., Smith, T., Ryan, L., and Christiani, D. C. (2007). Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms and skin lesions. Environ. Health Perspect. 115(3):341-345. (Pubitemid 46554430)
135. McDonald, C., Hoque, R., Huda, N., and Cherry, N. (2006). Prevalence of arsenic-related skin lesions in 53 widely-scattered villages of Bangladesh: An ecological survey. J. Health Popul. Nutr. 24:228-235.
136. Meza, M. M., Yu, L., Rodriguez, Y. Y., Guild, M., Tompson, D., Gandolf, A. J., and Klimecki, W. T. (2005). Developmentally restricted genetic determinants of human arsenic metabolism: Association between urinary methylated arsenic and CYT 19 polymorphisms in children. Environ. Health Perspect. 113(6):775-781.
137. Michaud, D. S., Wright, M. E., Cantor, K. P., Taylor, P. R., Virtamo, J., and Albanes, D. (2004). Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers. Am. J. Epidemiol. 160:853-859.
138. Milton, A. H., Hasan, Z., Shahidullah, S. M., Sharmin, S., Jakariya, M. D., Rahman, M., Dear, K., and Smith, W. (2004). Association between nutritional status and arsenicosis due to chronic arsenic exposure in Bangladesh. Int. J. Environ. Health Res. 14:99-108.
139. Milton, A. H., Smith, W., Rahman, B., Hasan, Z., Kulsum, U., Dear, K., Rakibuddin, M., and Ali, A. (2005). Chronic arsenic exposure and adverse pregnancy outcomes in Bangladesh. Epidemiology 16(1):82-86.
140. Milton, A. H., Rahman, H., Smith, W., Shrestha, R., and Dear, K. (2006). Water consumption patterns in rural Bangladesh: Are we understimating total arsenic load? J. Water Health 4:431-436.
141. Mitra, S. R., Guha Mazumder, D. N., Basu, A., Block, G., Haque, R., Samanta, S., Ghosh, N., Smith, M. M. H., von Ehrenstein, O. S., and Smith, A. H. (2004). Nutritional factors and susceptibility to arsenic-caused skin lesions in West Bengal, India. Environ. Health Perspect. 112:1104-1109.
142. Moore, L. E., Smith, A. H., Hopenhayn-Rich, C., Biggs, M. L., Kalman, D. A., and Smith, M. T. (1997). Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidemiol. Biomarkers Prev. 6:31-36.
143. Morales, K. H., Ryan, L., Kuo, T.-L., Wu, M.-M., and Chen, C.-J. (2000). Risk of internal cancers from arsenic in drinking water. Environ. Health Perspect. 108(7):655-661.
144. Mukherjee, B., Salavaggione, O. E., Pelleymounter, L. L., Moon, I., Ecklof, B. W., Schaid, D. J., Wieben, E. D., and Weinshilboum, R. M. (2006). Glutathione S-transferase omega 1 and omega 2 pharmacogenomics. Drug Metab. Dispos. 34:1237-1246.
145. Nagy, G., and Korom, I. (1983). Late skin symptoms of arsenic poisoning in the arsenic endemy in Bugac-Alsomonostor [in German]. Z. Hautkr. 58(13):961-964.
146. Nagy, G., Varga, G., Keresztes, T., and Márfai, L. (1975). Durch Genuß von hoch-arsenhaltigem Wasser verursachte chronische Arsenvergiftungen. Z. Hautkr. 50(5):201-211.
147. Nakadaira, H., Endoh, K., Katagiri, M., and Yamamoto, M. (2002). Elevated mortality from lung cancer associated with arsenic exposure for a limited duration. J. Occup. Environ. Med. 44:291-299.
148. National Research Council (1999). Arsenic in drinking water. National Academies Press, Washington, DC.
149. National Research Council (2001). Arsenic in drinking water: 2001 update. National Academies Press, Washington, DC.
150. Navas-Acien, A., Silbergeld, E. K., Streeter, R. A., Clark, J. M., Burke, T. A., and Guallar, E. (2006). Arsenic exposure and type 2 diabetes: A systematic review of the experimental and epidemiologic evidence. Environ. Health Perspect. 114(5):641-648.
151. Nesnow, S., Roop, B. C., Lambert, G., Kadiiska, M., Mason, R. P. , Cullen, W. R., and Mass, M. J. (2002). DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol. 15:1627-1634.
152. Nordenson, I., and Beckman, L. (1982). Occupational and environmental risks in and around a smelter in northern Sweden. VII. Reanalysis and follow-up of chromosomal aberrations in workers exposed to arsenic. Hereditas 96:175-181.
153. Nordenson, I., Beckman, G., Beckman, L., and Nordström, S. (1978). Occupational and environmental risks in and around a smelter in northern Sweden. II. Chromosomal aberrations in workers exposed to arsenic. Hereditas 88:47-50. (Pubitemid 8307693)
154. Nordenson, I., Sweins, A., and Beckman, L. (1981). Chromosome aberrations in cultured human lymphocytes exposed to trivalent and pentavalent arsenic. Scand. J. Work Environ. Health 7:277-281.
155. Ohno, K., Yanase, T., Matsuo, Y., Kimura, T., Rahman, M. H., Magara, Y., and Matsiu, Y. (2007). Arsenic intake via water and food by a population living in an arsenic-afected area of Bangladesh. Sci. Total Environ. 381:68-76.
156. Okoji, R. S., Yu, R. C., Maronpot, R. R., and Froines, J. R. (2002). Sodium arsenite administration via dringing water increases genome-wide and Ha-ras DNA hypomethylation in methyl-defcient C57BL/6J mice. Carcinogenesis 23:777-785.
157. Ostrosky-Wegman, P., Gonsebatt, M. E., Montero, R., Vega, L., Barba, H., Espinosa, J., Palao, A., Cortinas, C., Garcia-Vargas, G., del Razo, L.M., and Cebrian, M. (1991). Lymphocyte proliferation kinetics and genotoxic fndings in a pilot study on individuals chronically exposed to arsenic in Mexico. Mut. Res. 250:477-482.
158. Oya-Ohta, Y., Kaise, T., and Ochi, T. (1996). Induction of chromosomal aberrations in cultured human fbroblasts by inorganic and organic arsenic compounds and the diferent roles of glutathione in such induction. Mut. Res. 357:123-129.
159. Parish, W. R., and Burnett, J. W. (1987). Arsenic exposure: Te cutaneous manifestations. Cutis 40:401-402.
160. Piontek, M., Hengels, K.J., Borchard, F., and Strohmeyer, G. (1989). Nicht-zirrhotische Leberfbrose nach chronischer Arsenintoxikation. Dtsch. Med. Wochenschr. 114(43):1653-1657.
161. Pott, W. A., Benjamin, S. A., and Yang, R. S. H. (2001). Pharmacokinetics, metabolism, and carcinogenicity of arsenic. Rev. Environ. Contam. Toxicol. 169:165-214.
162. Pu, Y.-S., Yang, S.-M., Huang, Y.-K., Chung, C.-J., Huang, S. K., Chiu, A.W.-H., Yang, M.-H., Chen, C.-J., and Hsueh, Y.-M. (2007). Urinary arsenic profle afects the risk of urothelial carcinoma even at low arsenic exposure. Toxicol. Appl. Pharmacol. 218(2):99-106.
163. Rahman, M., Tondel, M., Ahmad, S. A., and Axelson, O. (1998). Diabetes mellitus associated with arsenic exposure in Bangladesh. Am. J. Epidemiol. 148:198-203.
164. Rahman, M., Vahter, M., Sohel, N., Yunus, M., Wahed, M. A., Streatfeld, P. K., Ekström, E.-C., and Persson, L. A. (2006). Arsenic exposure and age- and sex-specifc risk for skin lesions: a population based case-referent study in Bangladesh. Environ. Health Perspect. 114(12):1847-1852. (Pubitemid 44873684)
165. Ramírez, P., Eastmond, D. A., Laclette, J. P., and Ostrosky-Wegman, P. (1997). Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mut. Res. 386:291-298.
166. Reichard, J. F., Schnekenburger, M., and Puga, A. (2007). Long term low-dose arsenic exposure induces loss of DNA methylation. Biochem. Biophys. Res. Commun. 352:188-192.
167. Rossman, T.G. (2003). Mechanism of arsenic carcinogenesis: an integrated approach. Mut. Res. 533:37-65.
168. RoyChoudhury, A., Das, T., Sharma, A., and Talukder, G. (1996). Dietary garlic extract in modifying clastogenic efects of inorganic arsenic in mice: Two-generation studies. Mut. Res. 359:165-170.
169. Rudel, R., Slayton, T. M., and Beck, B. D. (1996). Implications of arsenic genotoxicity for dose response of carcinogenic efects. Regul. Toxicol. Pharmacol. 23(2):87-105.
170. Saha, K. C. 2003. Diagnosis of arsenicosis. J. Environ. Sci. Health A 38:255-272.
171. Saleha Banu, B., Danadevi, K., Jamil, K., Ahuja, Y. R., Visweswara, R. K., and Ishaq, M. (2001). In vivo genotoxic efect of arsenic trioxide in mice using comet assay. Toxicology 162:171-177. (Pubitemid 32706669)
172. Schaumlöfel, N., and Gebel, T. (1998). Heterogeneity of the DNA damage provoked by antimony and arsenic. Mutagenesis 12:281-286.
173. Schläwicke Engström, K., Broberg, K., Concha, G., Nermell, B., Warholm, M., and Vahter, M. (2007). Genetic polymorphisms infuencing arsenic metabolism-Evidence from Argentina. Environ. Health Perspect. 115(4):599-605.
174. Schoen, A., Beck, B., Sharma, R., and Dubé, E. (2004). Arsenic toxicity at low doses: epidemiological and mode of action considerations. Toxicol. Appl. Pharmacol. 198:253-267.
175. Schwartz, R. A. (1996). Premalignant keratinocytic neoplasms. J. Am. Acad. Dermatol. 35:223-242.
176. Schwerdtle, T., Walter, I., Mackiw, I., and Hartwig, A. (2003a). Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. Carcinogenesis 24(5):967-974.
177. Schwerdtle, T., Walter, I., and Hartwig, A. (2003b). Arsenite and its biomethylated metabolites interfere with the formation and repair of stable BPDE-induced DNA adducts in human cells and impair XPAzf and Fpg. DNA Repair 2:1449-1463.
178. Shannon, R. L., and Strayer, D. S. (1989). Arsenic-induced skin toxicity. Hum. Toxicol. 8:99-104.
179. Shen, S., Lee, J., Weinfeld, M., and Le, X. C. (2008). Attenuation of DNA damage-induced p53 expression by arsenic: a possible mechanism for arsenic co-carcinogenesis. Mol. Carcinog., in press.
180. Shi, H., Shi, X., and Liu, K. J. (2004). Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol. Cell. Biochem. 255:67-78.
181. Slob, W. (1999). Tresholds in toxicology and risk assessment. Int. J. Toxicol. 18(4):259-268.
182. Smith, A. H., Marshall, G., Yuan, Y., Ferreccio, C., Liaw, J., von Ehrenstein, O., Steinmaus, C., Bates, M. N., and Selvin, S. (2006). Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ. Health Perspect. 114:1293-1296.
183. Smith, N. M., Lee, R., Heitkemper, D. T., Caferky, K. D., Haque, A., and Henderson, A. K. (2006). Inorganic arsenic in cooked rice and vegetables from Bangladeshi households. Sci. Total Environ. 370:294-301.
184. Sordo, M., Herrera, L. A., Ostrosky-Wegman, P., and Rojas, E. (2001). Cytotoxic and genotoxic efects of As, MMA, and DMA on leukocytes and stimulated human lymphocytes. Teratog. Carcinog. Mutagen. 21:249-260.
185. Steinmaus, C., Yuan, Y., Bates, M. N., and Smith, A. H. (2003). Case-control study of bladder cancer and drinking water arsenic in the western United States. Am. J. Epidemiol. 158:1193-1201.
186. Steinmaus, C., Carrigan, K., Kalman, D., Atallah, R., Yuan, Y., and Smith, A. H. (2005). Dietary intake and arsenic methylation in a US population. Environ. Health Perspect. 113(9):1153-1159. (Pubitemid 41387652)
187. Steinmaus, C., Moore, L. E., Shipp, M., Kalman, D., Rey, O. A., Biggs, M. L., Hopenhayn, C., Bates, M. N., Zheng, S., Wiencke, J. K., and Smith, A. H. (2007). Genetic polymorphism in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic. J. Toxicol. Environ. Health A 70(2):159-170.
188. Stýblo, M., Drobná, Z., Jaspers, I., Lin, S., and Tomas, D. J. (2002). Te role of biomethylation in toxicity and carcinogenicity of arsenic: A research update. Environ. Health Perspect. 110 (Suppl 5):767-771.
189. Sykora, P., and Snow, E. T. (2008). Modulation of DNA polymerase beta-dependent base excision repair in cultured human cells after low dose exposure to arsenite. Toxicol. Appl. Pharmacol. 228(3):385-394.
190. Tapio, S., and Grosche, B. (2006). Arsenic in the aetiology of cancer. Mut. Res. 612(3):215-246.
191. Tice, R. R., Yager, J. W., Andrews, P., and Crecelius, E. (1997). Efect of hepatic methyl donor status on urinary excretion and DNA damage in B6C3F1 mice treated with sodium arsenite. Mut. Res. 386:315-334.
192. Tomas, D. J. (2007). Molecular processes in cellular arsenic metabolism. Toxicol. Appl. Pharmacol. 222(3):365-373.
193. Tollestrup, K., Frost, F. J., Cristiani, M., McMillan, G. P., Calderon, R. L., and Padilla, R. S. (2005). Arsenic-induced skin conditions identifed in southwest dermatology practices: An epidemiologic tool? Environ. Geochem. Health 27:47-53.
194. Tran, H.P., Prakash, A.S., Barnard, R., Chiswell, B., and Ng, J.C. (2002). Arsenic inhibits the repair of DNA damage induced by benzo(a)pyrene. Toxicol. Lett. 133:59-67.
195. Tsai, S.-Y., Chou, H.-Y., Te, H.-W., Chen, C.-M., and Chen, C.-J. (2003). Te efect of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology 24:747-753.
196. Tseng, H.-P., Wang, Y.-H., Wu, M.-M., Te, H.-W., Chiou, H.-Y., and Chen, C.-J. (2006). Association between chronic exposure to arsenic and slow nerve conduction velocity among adolescents in Taiwan. J. Health Popul. Nutr. 24(2):182-189.
197. Tseng, C. H. (2007). Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective. J. Environ. Sci. Health C 25(1):1-22.
198. Tseng, W. P. (1977). Efects and dose-response relationship of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 19:109-119.
199. Tseng, W. P., Chu, H. M., How, S. W., Fong, J. M., Lin, C. S., and Yeh, S. (1968). Prevalence of skin cancer in an endemic area of chronic arsenism in Taiwan. J. Natl. Cancer Inst. 40:453-463.
200. Vahter, M., and Concha, G. (2001). Role of metabolism in arsenic toxicity. Pharmacol. Toxicol. 89(1):1-5.
201. Vahter, M., Akeson, A., Lidén, C., Ceccatelli, S., and Berglund, M. (2007). Gender diferences in the disposition and toxicity of metals. Environ. Res. 104(1):85-95.
202. Valenzuela, O. L., Borja-Aburto, V. H., Garcia-Vargas, G. G., Cruz-Gonzalez, M. B., Garcia-Montalvo, E. A., Calderon-Aranda, E. S., and Del Razo, L. M. (2005). Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ. Health Perspect. 113(3):250-254.
203. Vega, L., Stýblo, M., Patterson, R., Cullen, W., Wang, C., and Germolec, D. (2001). Diferential efects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 172:225-232.
204. Vig, B. K., Figueroa, M. L., Cornforth, M. N., and Jenkins, S. H. (1984). Chromosome studies in human subjects chronically exposed to arsenic in drinking water. Am. J. Ind. Med. 6:325-338.
205. von Ehrenstein, O. S., Guha Mazumder, D. N., Hira-Smith, M., Ghosh, N., Yuan, Y., Windham, G., Ghosh, A., Haque, R., Lahiri, S., Kalman, D., Das, S., and Smith, A. H. (2006). Pregnancy outcomes, infant mortality, and arsenic in drinking water in West Bengal, India. Am. J. Epidemiol. 163(7):662-669.
206. Waalkes, M. P., Ward, J. M., Liu, J., and Diwan, B. A. (2003). Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol. Appl. Pharmacol. 186(1):7-17.
207. Waalkes, M. P., Liu, J., Ward, J. M., and Diwan, B. A. (2006a). Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen. Toxicol. Appl. Pharmacol. 215(3):295-305.
208. Waalkes, M. P., Liu, J., Ward, J. M., Powell, D. A., and Diwan, B. A. (2006b). Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment. Cancer Res. 66(3):1337-1345.
209. Walter, I., Schwerdtle, T., Tuy, C., Parsons, J. L., Dianov, G. L., and Hartwig, A. (2007). Impact of arsenite and its methylated metabolites on PARP-1 activity, PARP-1 gene expression and poly(ADP-ribosyl)ation in cultured human cells. DNA Repair 6:61-70.
210. Wang, T.-S., Shu, Y.-F., Liu, Y.-C., Jan, K.-Y., and Huang, H. (1997). Glutathione peroxidase and catalase modulate the genotoxicity of arsenite. Toxicology 121:229-237.
211. Wang, T.-S., Chung, C.-H., Wang, A. S. S., Bau, D.-T., Samikkannu, T., Jan, K.-Y., Cheng, Y.-M., and Lee, T.-C. (2002). Endonuclease III, formamidopyrimidine-DNA glycosylase, and proteinase K additively enhance arsenic-induced DNA strand breaks in human cells. Chem. Res. Toxicol. 15(10):1254-1258.
212. Wang, A., Holladay, S., Wolf, D., Ahmed, S., and Robertson, J. (2006). Reproductive and developmental toxicity of arsenic in rodents: A review. Int. J. Toxicol. 25:319-331.
213. Wang, S.-X., Wang, Z.-H., Cheng, X.-T., Li, J., Sang, Z.-P., Zhang, X.-D., Han, L.-L., Qiao, X.-Y., Wu, Z.-M., and Wang, Z.-Q. (2007). Arsenic and fuoride exposure in drinking water: Children's IQ and growth in Shanyin County, Shanxi Province, China. Environ. Health Perspect. 115(4):643-647.
214. Warner, M. L., Moore, L. E., Smith, M. T., Kalman, D. A., Fanning, E., and Smith, A. H. (1994). Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol. Biomarkers Prev. 3(7):583-590.
215. Wasserman, G. A., Liu, X., Parvez, F., Ahsan, H., Factor-Litvak, P., van Geen, A., Slavkovich, V. , LoIacono, N. J., Cheng, Z., Hussain, I., Momotaj, H., and Graziano, J. H. (2004). Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ. Health Perspect. 112(9):1329-1333.
216. Wasserman, G. A., Liu, X., Parvez, F., Ahsan, H., Factor-Litvak, P., Kline, J., van Geen, A., Slavkovich, V., LoIacono, N. J., Levy, D., Cheng, Z., and Graziano, J. H. (2007). Water arsenic exposure and intellectual function in six-year-old children in Araihazar, Bangladesh. Environ. Health Perspect. 115(2):285-289.
217. Watanabe, C. (2001). Environmental arsenic exposure in Bangladesh: Water versus extra-water intake of arsenic. Environ Sci 8:459-466.
218. Watanabe, C., Kawata, A., Sudo, N., Sekiyama, M., Inaoka, T., Bae, M., and Ohtsuka, R. (2004). Water intake in an Asian population living in arsenic-contaminated area. Toxicol. Appl. Pharmacol. 198:272-282.
219. Wei, M., Wanibuchi, H., Morimura, K., Iwai, S., Yoshida, K., Endo, G., Nakae, D., and Fukushima, S. (2002). Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis 23:1387-1397.
220. Williams, P. N., Price, A. H., Raab, A., Hossain, S. A., Feldmann, J., and Meharg, A. A. (2005). Variation in arsenic speciation and concentration in paddy rice related to dietary exposure. Environ. Sci. Technol. 39:5531-5540.
221. Williams, P. N., Islam, M. R., Adomako, E. E., Raab, A., Hossain, S. A., Zhu, Y. G., Feldmann, J., and Meharg, A. A. (2006). Increase in rice grain arsenic for regions of Bangladesh irrigating paddies with elevated arsenic in groundwaters. Environ. Sci. Technol. 40:4903-4908.
222. Witkiewicz-Kucharczyk, A., and Bal, W. (2006). Damage of zinc fngers in DNA repair proteins, a novel molecular mechanism in carcinogenesis. Toxicol. Lett. 162:29-42.
223. World Health Organization (1993). Guidelines for drinking-water quality. Vol.1. Recommendations. 2nd ed.
224. World Health Organisation, Geneva. World Health Organization (2001). Environmental health criteria 224, arsenic and arsenic compounds. 2nd ed.
225. World Health Organization, Geneva. Wu, M.-M., Kuo, T.-L., Hwang, Y.-H., and Chen, C.-J. (1989). Dose-response relation between arsenic well water and mortality from cancer. Am. J. Epidemiol. 130:1123-1132.
226. Yamanaka, K., Hasegawa, A., Sawamura, R., and Okada, S. (1989). Dimethylated arsenics induce DNA strand breaks in lung via the production of active oxygen in mice. Biochem. Biophys. Res. Commun. 165:43-50.
227. Yamanaka, K., Kato, K., Mizoi, M., An, Y., Takabayashi, F., Nakano, M., Hoshino, M., and Okada, S. (2004). Te role of active arsenic species produced by metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesis. Toxicol. Appl. Pharmacol. 198(3):385-393.
228. Yamauchi, H., Aminaka, Y., Yoshida, K., Sun, G., Pi, J., and Waalkes, M. P. (2004). Evaluation of DNA damage in patients with arsenic poisoning: Urinary 8-hydroxydeoxyguanine. Toxicol. Appl. Pharmacol. 198(3):291-296.
229. Yang, C., and Frenkel, K. (2002). Arsenic-mediated cellular signal transduction, transcription factor activation, and aberrant gene expression: implications in carcinogenesis. J. Environ. Pathol. Toxicol. Oncol. 21(4):331-342.
230. Yu, R. C., Hsu, K. H., Chen, C. J., and Froines, J. R. (2000). Arsenic methylation capacity and skin cancer. Cancer Epidemiol. Biomarkers Prev. 9:1259-1262.
231. Zhang, T. C., Schmitt, M. T., and Mumford, J. L. (2003). Efects of arsenic on telomrase and telomeres in relation to cell proliferation and apoptosis in human keratinocytes and leukemia cells in vitro. Carcinogenesis 24:1811-1817.